What the results of Wegovy’s longest clinical trial yet show about ...
May 13, 2024 · New analyses of the longest clinical trial yet of the weight-loss drug Wegovy are shedding light on how quickly it helps people lose weight, how long they sustain that weight …
FDA Approves First Treatment to Reduce Risk of Serious Heart …
Today, the U.S. Food and Drug Administration approved a new indication for use for Wegovy (semaglutide) injection to reduce the risk of cardiovascular death, heart attack and stroke in …
FDA approves Wegovy to reduce heart attack and stroke risk - NBC News
Mar 8, 2024 · The blockbuster weight loss drug Wegovy is now approved to reduce heart disease risk, drugmaker Novo Nordisk said Friday. The Food and Drug Administration has updated the …
Wegovy approved to lessen heart attack, stroke risk in overweight ...
Mar 8, 2024 · The popular weight-loss drug can now be used to reduce the risk of stroke, heart attacks and other serious cardiovascular problems in patients who are overweight or who have …
Weight-loss drug Wegovy produces ‘largest benefit ever seen’ for ...
Aug 25, 2023 · The study of 529 patients, funded by drugmaker Novo Nordisk, found that a 2.4-milligram weekly dose of semaglutide, sold as Wegovy for weight loss, led to an improvement …
FDA Approves New Drug Treatment for Chronic Weight …
FDA approves Wegovy (semaglutide) injection for chronic weight management in adults with obesity or overweight with at least one weight-related condition.
Wegovy shown to reduce risk of heart attack, stroke in major ...
Aug 8, 2023 · CNN — The weight loss drug Wegovy was shown to reduce the risk of heart attack, stroke or heart-related death by 20% in what’s being called a landmark clinical trial in people …
Why weight-loss drug Wegovy shows promise for heart disease - NBC News
Nov 11, 2023 · The weight-loss drug Wegovy can reduce the risk of heart attacks and strokes by 20% in adults with heart disease and obesity, according to new research.
Wegovy shown to cut risk of stroke and heart attacks ... - NBC News
Aug 8, 2023 · The popular obesity drug Wegovy cuts the risk of cardiovascular events, such as heart attack and stroke, by 20%, drugmaker Novo Nordisk said Tuesday. The findings are the …
Novo Nordisk Says Wegovy Improved Patients’ Liver Disease
Nov 1, 2024 · The trial showed that semaglutide, the main ingredient in Novo’s Wegovy, helped 37% of patients see an improvement in their liver fibrosis, while 62.9% achieved resolution of …